Restoring invisible and abandoned trials – new podcast episode

Communications / 01 October 2020

Photo by Pau Casals on Unsplash

In the new episode of the Drug Safety Matters podcast, explore the problem of the data we don't see and find out what can be done to peel back the curtain.


Clinical trials are the “gold standard” of evidence-based medicine – the best way we have to test whether a drug is safe and effective before it enters the market. But if trial data is poorly reported or – even worse – left unpublished, how are we supposed to determine the true value of a medical treatment?

Peter Doshi, associate editor at The BMJ and founder of the Restoring Invisible and Abandoned Trials (RIAT) Support Center, has made it his mission to fix the problem and improve data transparency for good.

Subscribe by visiting the Drug Safety Matters website or listen in right here:

Learn more

To find out a lot more about Peter Doshi and his work, be sure to visit the RIAT Support Center here.

Peter Doshi on Drug Safety Matters. Photo: UMC

Related Articles

Pharmacovigilance: Back to the Future with ISoP 2025

Traversing the social media landscape

Building a global network of credible vaccine safety information websites

You may also like

Pharmacovigilance: Back to the Future with ISoP 2025

The theme of this year’s conference is inspired by Cairo’s rich cultural and scientific history and commitment to advancing drug safety and regulatory science.

Communications / 19 March 2025

Building a global network of credible vaccine safety information websites

With the misinformation pandemic still rife on the internet, finding websites with scientifically accurate vaccine information is quite the task. The VSN aims to change that.

Communications / 17 June 2024

Traversing the social media landscape

Social media is prime real estate for healthcare communicators to connect with their audiences. But it is also constantly evolving. How can we navigate this dynamic online terrain?

Communications / 14 January 2025